JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Strona główna・Stock List・Ascendis Pharma A/S

Search

Ascendis Pharma A/S

Closed

SectorHealthcare

219.69 -4.24

Overview

Share price change

24h

Current

Min

219.69

Max

223.05

Key metrics
By Trading Economics
Income	28M -33M
Sales	32M 245M
Profit margin	-13.56
Employees	1,189
EBITDA	68M 15M

Recommendations
By TipRanks
Recommendations	Strong Buy
12 Months Forecast	+34.26% upside

Dividends
By Dow Jones
Next Earnings	7 maj 2026

Market Stats
By TradingEconomics
Market Cap	14B
Previous open	223.93
Previous close	219.69

News Sentiment

By Acuity

50%

50%

155 / 347 Ranking in Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

157.66 / 167.29 Support & Resistance

Ascendis Pharma A/S Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

3 maj 2026, 23:47 UTC

Earnings

National Australia Bank Warns of Economic Shock as 1st Half Profit Falls -- Update

3 maj 2026, 22:35 UTC

Earnings

National Australia Bank Holds Dividend Despite 19% 1st Half Profit Drop

3 maj 2026, 23:39 UTC

Market Talk

Gold Edge Higher Amid Signs of Resilience -- Market Talk

3 maj 2026, 23:34 UTC

Market Talk

Oil Declines Amid Mild Risk-on Sentiment -- Market Talk

3 maj 2026, 23:32 UTC

Earnings

National Australia Bank Warns of Economic Shock as 1H Profit Falls -- Update

3 maj 2026, 23:30 UTC

Market Talk

Nickel Industries Result Shows Power of Higher Prices -- Market Talk

3 maj 2026, 23:20 UTC

Market Talk

RBA Likely to Hike Rates; Guidance and Board Split Key -- Market Talk

3 maj 2026, 23:16 UTC

Acquisitions, Mergers, Takeovers

GameStop Is Offering to Buy eBay for $56 Billion, CEO Ryan Cohen Says -- WSJ

3 maj 2026, 22:57 UTC

Acquisitions, Mergers, Takeovers

GameStop Is Offering to Buy eBay For $56 Billion, CEO Ryan Cohen Says -- WSJ

3 maj 2026, 22:57 UTC

Acquisitions, Mergers, Takeovers

GameStop Has Roughly 5% Stake in eBay, Cohen Says -- WSJ

3 maj 2026, 22:57 UTC

Acquisitions, Mergers, Takeovers

GameStop Offering to Buy eBay for $125 a Share, or About $56 Billion, CEO Ryan Cohen Says -- WSJ

3 maj 2026, 22:57 UTC

Acquisitions, Mergers, Takeovers

GameStop Is Prepared to Run Proxy Fight If eBay Isn't Receptive to a Deal, Cohen Says -- WSJ

3 maj 2026, 22:57 UTC

Acquisitions, Mergers, Takeovers

GameStop Has Around $20 Billion in Debt Financing Committed From TD Bank, Cohen Says -- WSJ

3 maj 2026, 22:45 UTC

Market Talk

Global Equities Roundup: Market Talk

3 maj 2026, 22:45 UTC

Market Talk

Low-Cost Miners in Spotlight Amid High Energy Prices -- Market Talk

3 maj 2026, 22:20 UTC

Earnings

National Australia Bank Holds Dividend Despite 19% 1H Profit Drop

3 maj 2026, 22:08 UTC

Earnings

NAB's 1H Included Previously Announced A$1.35B Software Amortization Charge>NAB.AU

3 maj 2026, 22:05 UTC

Earnings

NAB 1H Net Interest Income A$9.16B Vs. A$8.445B>NAB.AU

3 maj 2026, 22:05 UTC

Earnings

NAB 1H Credit Impairment Charge A$706M Vs. A$348M>NAB.AU

3 maj 2026, 22:05 UTC

Earnings

NAB 1H Operating Expenses A$5.02B Vs. A$4.81B>NAB.AU

3 maj 2026, 22:04 UTC

Earnings

NAB 1H Net Interest Margin 1.81%>NAB.AU>NAB.AU

3 maj 2026, 22:03 UTC

Earnings

NAB 1H Cash Return on Equity Ex-Large Notable Items 11.6%>NAB.AU

3 maj 2026, 22:03 UTC

Earnings

NAB 1H Cash Return on Equity 8.5%>NAB.AU

3 maj 2026, 22:02 UTC

Earnings

NAB 1H CET1 Capital Ratio 11.65% Vs. 12.01%>NAB.AU

3 maj 2026, 22:02 UTC

Earnings

NAB 1H Cash Earnings A$2.64B>NAB.AU

3 maj 2026, 22:02 UTC

Earnings

NAB 1H Cash Earnings Ex-Notable Items A$3.59B Vs. A$3.58B>NAB.AU

3 maj 2026, 22:01 UTC

Earnings

National Australia Bank Keeps Dividend at A$0.85 >NAB.AU

3 maj 2026, 22:01 UTC

Earnings

National Australia Bank 1H Rev A$11.16B Vs. A$10.28B >NAB.AU

3 maj 2026, 22:01 UTC

Earnings

National Australia Bank 1H Net A$2.75B Vs. Net A$3.41B >NAB.AU

3 maj 2026, 15:06 UTC

Earnings

Berkshire's Greg Abel Marks His First Annual Meeting as CEO. We'd Give Him a B-Plus. -- Barrons.com

Peer Comparison

Price change

Ascendis Pharma A/S Forecast

Price Target

By TipRanks

34.26% upside

12 Months Forecast

Average 296.62 USD 34.26%

High 342 USD

Low 255 USD

Based on 13 Wall Street analysts offering 12 month price targets forAscendis Pharma A/S - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

13 ratings

13

Buy

0

Hold

0

Sell

Based on 13 analysts giving stock ratings to Ascendis Pharma A/S - Dist in the past 3 months.

Technical Score

By Trading Central

157.66 / 167.29Support & Resistance

Recent bearish events outweigh bullish events.

Bullish events outweigh bearish events.

All events are bullish.

Sentiment

By Acuity

155 / 347 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

Other stocks from the sector

JNJ

Johnson and Johnson

227.46

UNH

UnitedHealth Group Inc

369.01

TMO

Thermo Fisher Scientific Inc

469.28

ISRG

Intuitive Surgical Inc

457.59

ABT

Abbott Laboratories

89.51

Live chat